Skip to content

Webinar
The new AHA guidelines // The evolving consensus on stroke imaging
March 24, 3:00 PM PT

Register

Season 1 • Episode 5

What’s Next Tech? | Radiology Rewired

Episode Overview

In Episode 5 of Radiology Rewired, Dr. Vivek Singh speaks with Dr. David Stoffel, Chief Business Officer at RapidAI, about what changes when clinical AI moves beyond pilots and becomes part of a hospital’s core infrastructure.

Rather than focusing on whether AI works, the conversation looks at how hospitals operationalize AI at scale. Dr. Stoffel shares perspective from across medicine, business, and healthcare technology to explain why leadership decisions, governance models, and shared access determine whether AI actually shapes clinical decisions.

Topics include how hospitals move from isolated tools to platforms, why efficiency gains alone rarely justify investment, and what it takes to embed AI into real workflows without adding friction for clinicians.

This episode offers a practical, execution-focused view of how clinical AI becomes a durable, system-wide capability inside complex healthcare organizations.

Episode highlights

00:00

Introduction: when clinical AI becomes infrastructure

01:10

Moving beyond AI pilots

02:30

Why efficiency does not equal impact

03:50

How hospitals operationalize AI decisions

05:10

Leadership, governance, and shared access

06:40

Why integration across specialties matters

08:15

Stroke care as an infrastructure model

10:05

Predictive AI and decision-making at scale

12:20

Avoiding cognitive burden in AI deployment

14:20

What clinical AI looks like when it sticks

About the host

dr-vivek-singh
Vivek Singh, MD
Neuroradiologist, MUSC

Dr. Singh is a board-certified neuroradiologist and assistant professor at MUSC, where he completed his diagnostic radiology residency and neuroradiology fellowship, serving as chief resident in his final year. His expertise spans the full spectrum of diagnostic imaging, with a strong interest in stroke and brain tumor imaging, while also regularly interpreting general studies and performing a range of image-guided procedures.

A graduate of the Virginia Tech Carilion School of Medicine with dual undergraduate degrees in Human Nutrition and Biochemistry from Virginia Tech, Dr. Singh developed a deep interest in AI during training. He focuses on how AI can improve early disease detection, expand therapeutic imaging, enhance screening programs, and triage critical findings. He is particularly interested in the evolving role of radiologists as information integrators, combining AI insights with imaging, genomics, and clinical data to guide diagnosis and treatment.

About the guest

Dr David Stoffel
Dr. David Stoffel
Chief Business Officer at RapidAI

David Stoffel, M.D., has spent more than 20 years developing and commercializing innovative technologies and services in the medical device industry.

David has an extensive track record of success in scaling healthcare businesses. Notably, he led marketing and corporate development at Intuitive Surgical, contributing significantly to establishing the Da Vinci surgical robotic system as a new surgical standard of care. He also helped launch and lead the Mobile Cardiac Telemetry business at iRhythm Technologies, one of the fastest growing digital health companies and was Chief Business Officer at Ceribell, maker of an innovative point-of-care EEG solution.

Earlier in his career, David was a partner at a healthcare venture capital firm, where he invested in and helped build early-stage companies. He started his career in investment banking focused on corporate finance.

At RapidAI, David leads a variety of commercial, clinical, and operational teams including Marketing, Customer Retention and Success, Clinical Affairs, Training & Education, Corporate Development, and Finance.

David has a BA in Economics from Stanford University and received an MD and MBA from the University of Chicago.